The Sudeep Pharma IPO entered its second day with solid interest across investor categories. By mid-morning on November 24, the subscription numbers told a clear story of rising demand as bids continued to build across the book.
For many tracking Sudeep Pharma IPO news, the momentum on Day 2 highlighted the early strength of the offering, especially as the issue moved closer to its closing date.
Market Performance: Strong Bidding Momentum on Day 2
The public issue witnessed a steady flow of bids through the first half of the session.
By 11 am, the Sudeep Pharma IPO had already been subscribed to more than 2.5 times.
The interest wasn’t evenly distributed—some brackets moved quickly, while others built gradually through the session.
Day 2 Subscription Snapshot
- Total Bids: Nearly 2.6 crore shares
- Offer Size: Approximately 1.06 crore shares
The demand pattern reflected a well-rounded response from both retail and non-institutional participants.
Main News: Category-Wise Subscription Trends
Each investor segment showed distinct activity levels, and the numbers made the trend clear.
Category Breakdown
- Non-Institutional Investors (NII): Subscribed 5x
- Retail Investors: Subscribed nearly 3x
- Qualified Institutional Buyers (QIB): Subscribed 10% of the reserved portion
The retail side picked up sharply, mirroring the broader interest in mid-sized pharma players entering the capital market. Meanwhile, NIIs drove early enthusiasm with high bidding multiples, pushing the overall subscription figures above 2.5x early in the day.
Company Details: Key Information About the Sudeep Pharma IPO
The Sudeep Pharma IPO comes from a technology-led manufacturer involved in producing excipients and speciality ingredients used across pharmaceuticals, food, and nutrition sectors.
The offer blends fresh equity with a significant offer-for-sale component, making it one of the notable issues of the month.
Sudeep Pharma IPO Key Details
- Total Issue Size: ₹895 crore
- Fresh Issue: ₹95 crore
- Offer for Sale (OFS): 1.3 crore shares worth ₹800 crore
- Price Band: ₹563–₹593 per share
- IPO Open Dates: November 21 to November 25
- Minimum Retail Investment:
- 25 shares per lot
- At upper band: ₹14,825
- Allotment Date: Likely November 26
- Listing Date: Scheduled for November 28
The company also outlined the planned use of funds from the fresh issue.
Utilisation of Fresh Issue Amount
- ₹75.81 crore for capital expenditure, primarily for machinery at its Nandesari Facility 1, Gujarat
- Remaining proceeds allocated toward general corporate purposes.
These details underline how the company aims to expand production capabilities while maintaining operational flexibility.
Summary: Sudeep Pharma IPO Maintains Traction into Day 2
The Sudeep Pharma IPO subscription numbers on Day 2 showed steady enthusiasm, with the issue crossing 2.5x overall and strong support from NIIs and retail bidders. With its issue size of ₹895 crore, defined price band of ₹563–₹593, and clear utilisation plan for the fresh issue, the offering continues to draw attention as it heads into the final bidding days.
The momentum reflects active participation across investor categories, marking it as one of the more closely tracked public issues in the ongoing IPO cycle.
Easy & quick
Leave A Comment?